In 2016, Ge et al found that the expression of IL-37 was decreased in Non-small cell lung cancer (NSCLC) tissues and the antitumor activity of IL-37 was found by inhibition of angiogenesis in vitro and in vivo [22]. This evidence concerns the gene IL37 and non-small cell lung carcinoma.